With a robust background in healthcare investments, the fund manager has successfully executed over 30 deals across North America and Europe. Their strategic focus on later-stage companies has yielded notable exits, emphasizing a data-driven approach that prioritizes operational efficiency. Active in sectors such as biotechnology and medical devices, they leverage thematic investment strategies to identify high-growth opportunities. Their experience reflects a commitment to delivering value through deep industry insights and disciplined execution.